Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972154priorityCriticalpatent/ECSP972154A/en
Publication of ECSP972154ApublicationCriticalpatent/ECSP972154A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
Esta invención se refiere a derivados tricíclicos sustituidos con finilamino que son útiles en el tratamiento de enfermedades hiperproliferativas, tales como cánceres, en mamíferos. Esta invención también se refiere a un procedimiento de uso de dichos compuestos en el tratamiento de enfermedades hiperproliferativas en mamíferos, especialmente en seres humanos, y a composiciones farmacéuticas que contienen dichos compuestos.This invention relates to finylamino substituted tricyclic derivatives that are useful in the treatment of hyperproliferative diseases, such as cancers, in mammals. This invention also relates to a method of using said compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and to pharmaceutical compositions containing said compounds.
ECSP9721541997-06-181997-06-18
TRICYCLIC DERIVATIVES REPLACED WITH PHENYLAMINE
ECSP972154A
(en)
MESILATE COMPOSITE OF N- (3-ETINYL PHENYL) -6,7-BIS- (2-METOXYETOXI) -4-QUINAZOLINAMINE, COMPOSITIONS THAT CONTAIN THEM AND THEIR USE OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES.